Treatment Trials

2 Clinical Trials for Various Conditions

Focus your search

      COMPLETED
      Persistence of Effect and Safety of Valbenazine for the Treatment of Tardive Dyskinesia
      Description

      This is a Phase 4, randomized, double-blind, placebo-controlled study to evaluate the persistence of effect of valbenazine 40 mg and 80 mg.

      Conditions
      Tardive Dyskinesia (TD)
      Talk to us
      COMPLETED
      The Potential for Clinical Dependence and Withdrawal Symptoms Associated With Valbenazine
      Description

      This is a Phase 4, randomized, double-blind, placebo-controlled study to evaluate the potential for clinical dependence and withdrawal symptoms associated with valbenazine.

      Conditions
      Tardive Dyskinesia (TD)
      Talk to us